Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Fondation Ophtalmologique Adolphe de Rothschild appears in 55 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials55
Recruiting shown7
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

55 shown
Safety of a Strategy Combining Etanercept Administration With Repeated Contrast Ultrasound in Patients With Alzheimer's DiseaseNCT06585384 · lead sponsor · 2025-04-15
RECRUITING
Detection of Spinal Cord Lesions Using the MP2RAGE Sequence in Inflammatory Diseases of the NeuraxisNCT06589999 · lead sponsor · 2024-07-31
RECRUITING
Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions ResearchNCT04906928 · lead sponsor · 2023-10-25
RECRUITING
Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle GlaucomaNCT05264818 · lead sponsor · 2022-05-06
RECRUITING
Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension.NCT05050864 · lead sponsor · 2022-03-02
RECRUITING
OCT-Angiography and Adaptive Optics in Patients With Memory ImpairmentNCT04389437 · lead sponsor · 2020-06-26
RECRUITING
Genetic and Electrophysiologic Study in Focal Drug-resistant EpilepsiesNCT02890641 · lead sponsor · 2015-12-17
RECRUITING
MS and Health CohortNCT07645703 · lead sponsor · 2026-06-11
NOT_YET_RECRUITING
Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority TrialNCT05999604 · lead sponsor · 2023-11-09
ACTIVE_NOT_RECRUITING
Comparison of the Performance of an Optimized 3D EPI SWI Sequence and a Non-EPI QSM SWI Sequence in Detecting the Central Vein Sign in Patients With Multiple SclerosisNCT04705870 · lead sponsor · 2021-06-02
COMPLETED
Evaluation of a Millimeter Wave Emission Bracelet for Improving Parkinson's Disease SymptomsNCT04648150 · lead sponsor · 2021-05-18
COMPLETED
Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5TNCT04707144 · lead sponsor · 2021-05-06
COMPLETED
Effect of Individualized Versus Standard Bp Management During MT for Anterior Ischemic StrokeNCT04352296 · lead sponsor · 2021-03-08
COMPLETED
Evaluation of the Reproducibility of the Measurement of the QSM Signal (Quantitative Susceptibility Mapping)NCT04465448 · lead sponsor · 2020-12-17
TERMINATED
Optical Coherence Tomography and Optic Neuritis Not Related to Multiple SclerosisNCT03963310 · lead sponsor · 2020-09-14
COMPLETED
Assessment of Language Disorders in Multiple Sclerosis PatientsNCT04465084 · lead sponsor · 2020-08-17
COMPLETED
Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune DiseaseNCT04345159 · lead sponsor · 2020-04-17
COMPLETED
Evaluation of the Neurological and Psychiatric Adverse Events of Dolutegravir and Bictegravir in Real LifeNCT03964584 · lead sponsor · 2019-09-01
WITHDRAWN
Evaluation of Neurologic and Psychiatric Adverse Events of Several Antiretroviral Drugs in Real Life SettingNCT02882230 · lead sponsor · 2018-11-19
TERMINATED
Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular EdemaNCT03603990 · lead sponsor · 2018-09-01
WITHDRAWN
Prevalence of Age Related Macular Degeneration (ARMD) in Parkinson's Patients and Assesment of the Role of L-DOPANCT03415984 · lead sponsor · 2018-01-19
COMPLETED
3D FLAIR Versus Coronal T2-WI MRI in Detecting Optic Neuritis (FLACON)NCT04792866 · lead sponsor · 2018-01-01
COMPLETED
Post-COntrast 3D SE T1 Versus Coronal SE T1-WI MRI in Detecting Optic Neuritis (COCON)NCT04793087 · lead sponsor · 2018-01-01
COMPLETED
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years OldNCT03268109 · lead sponsor · 2017-09-22
COMPLETED
Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis LesionsNCT03268239 · lead sponsor · 2017-08-02
COMPLETED
Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarateNCT02901106 · lead sponsor · 2017-05-23
TERMINATED
Disability, MRI Lesions and Thickness of Retinal Fibers: Evaluation 15 Years After a First Episode of DemyelinationNCT03268096 · lead sponsor · 2017-05-03
COMPLETED
Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With DiabetesNCT02876744 · lead sponsor · 2017-04-04
COMPLETED
3D Phase Sensitive Inversion Recuperation MRI to Detect and Characterize Multiple Sclerosis Spinal Cord LesionsNCT02896647 · lead sponsor · 2016-12-14
TERMINATED
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).NCT02688465 · lead sponsor · 2016-09-05
TERMINATED
Disability, Perceived Social Support and Quality of Life in Multiple SclerosisNCT02880553 · lead sponsor · 2016-08-23
COMPLETED
Pupillometry Dynamic Measures in Patients Without Ocular or Neurological DiseaseNCT02894281 · lead sponsor · 2016-06-01
COMPLETED
Effect of Elevated Intraocular Pressure in Glaucoma Patients During Femtolaser Cataract SurgeryNCT02835482 · lead sponsor · 2016-04-14
TERMINATED
Evaluation of the Possibility to Delegate Glaucoma Surveillance to Orthoptists in HospitalNCT02876185 · lead sponsor · 2016-04-08
COMPLETED
Micropulsed Laser in Association With Anti-VEGF for the Treatment of Macular Edema in Diabetic Patients (LAMED).NCT02650050 · lead sponsor · 2016-01-19
TERMINATED
Evaluation of the Protective Role of the L-DOPA Against Age Related Macular Degeneration in Parkinson's PatientsNCT02863640 · lead sponsor · 2015-12-14
TERMINATED
Action-effect Anticipation in Patients With Parkinson's Disease : A Study of the Sensory Attenuation Marker.NCT02894333 · lead sponsor · 2015-12-01
TERMINATED
Prognosis of a First-Ever Stroke in Persons Living With HIVNCT02748252 · lead sponsor · 2015-12-01
TERMINATED
Spinal Cord Stimulation in the Treatment of Parkinson's DiseaseNCT02381951 · lead sponsor · 2015-11-24
COMPLETED
Stimulus-response and Parkinson's Disease (SRlearning)NCT02515136 · lead sponsor · 2015-07-01
TERMINATED
Dynamic ASPECTS of Internal PRE-ACTIVATION of Effects Sensors of Voluntary ACTION in PARKINSON's DiseaseNCT02894320 · lead sponsor · 2015-03-01
COMPLETED
Feasibility of Continuous Sleep Recording in Patients Undergoing Deep Brain Stimulation for Parkinson's DiseaseNCT02907723 · lead sponsor · 2014-12-01
COMPLETED
Does Micro-albuminuria is a Predictive Factor for Cognitive Impairment in Persons Living With HIV (PLHIV) Who Achieve cART-sustained Immunovirological Control ?NCT02852772 · lead sponsor · 2014-07-01
COMPLETED
The Microvascular Brain Retina And Kidney StudyNCT02210130 · lead sponsor · 2014-05-01
COMPLETED
French Adaptation of the California Card Sorting Task (CCST) in Multiple SclerosisNCT02887352 · lead sponsor · 2014-03-01
COMPLETED
Paris Visual Learning Test: a New French Task for Assess Visual Learning and Memory to Multiple Sclerosis PatientsNCT02893683 · lead sponsor · 2013-12-19
COMPLETED
Assessment of Age-related Hearing Loss in HIV-1 PatientsNCT02154971 · lead sponsor · 2013-11-18
COMPLETED
Prevalence of Cerebral Small Vessel Disease in HIV Infected PatientsNCT02082574 · lead sponsor · 2013-07-01
COMPLETED
Revealing Increased Axonal Loss in Treated HIV PatientsNCT02003989 · lead sponsor · 2013-05-01
COMPLETED
Improved Detection of Multiple Sclerosis Plaques in Inversion Recovery by Optimization of Sequence ParametersNCT03108573 · lead sponsor · 2012-12-12
COMPLETED
Interest of Dynamic Measures of the Pupil in Optic NeuritisNCT02004054 · lead sponsor · 2012-12-01
COMPLETED
Do CCR5 Antagonists Improve the Overall Survival of Patients With AIDS-related Progressive Multifocal Leucoencephalopathy?NCT03969550 · lead sponsor · 2008-01-01
COMPLETED
Retrospective Study of the Survival of Patients Suffering From Hiv-related Progressive Multifocal LeukoencephalopathyNCT02895581 · lead sponsor · 2006-01-01
COMPLETED
Electrophysiological Study of Spatiotemporal Gait Parameters in Patients in Early Stage of Multiple SclerosisNCT02896933 · lead sponsor
COMPLETED
Economic and Social Disparities and Breast CancerNCT02948478 · collaborator · 2016-12-01
COMPLETED

Drugs studied in this sponsor's trials

3 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Fondation Ophtalmologique Adolphe de Rothschild as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
apomorphine1
dimethyl fumarate1
ocrelizumab Injection [Ocrevus]1
apomorphine RxCUI 1043 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial dimethyl fumarate RxCUI 1373478 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ocrelizumab Injection [Ocrevus] RxCUI 1876383 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor54
collaborator1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.